Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta

J Interferon Cytokine Res. 2005 Jul;25(7):395-406. doi: 10.1089/jir.2005.25.395.

Abstract

The neurotransmitter dopamine counteracts T cell functions through its specific receptor subtype D5R but favors T cell proliferation and adhesion when acting on D3R. We found diminished mRNA and protein levels of D5R, but not of D3R, in peripheral blood mononuclear cells (PBMCs) from untreated multiple sclerosis (MS) patients. Dopamine reduced T cell proliferation, secretion of interferon-gamma (IFN-gamma), and production of matrix metalloproteinase-9 (MMP-9) mRNA in PBMCs from controls but not from MS patients. By contrast, reduced levels of D3R and renewed dopamine-associated regulatory functions were found in PBMCs from IFN-beta treated MS patients. Failure of the dopaminergic system of lymphocytes may lessen the threshold of T cell activation and sustain the pathogenic cascade of MS.

MeSH terms

  • Adult
  • Dopamine / pharmacology*
  • Female
  • Humans
  • Interferon-beta / therapeutic use*
  • Interferon-gamma / biosynthesis
  • Lymphocyte Activation*
  • Male
  • Matrix Metalloproteinase 9 / biosynthesis
  • Matrix Metalloproteinase 9 / genetics
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • RNA, Messenger / metabolism
  • Receptors, Dopamine D1 / genetics
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / genetics
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Dopamine D3
  • Receptors, Dopamine D5
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • DRD3 protein, human
  • DRD5 protein, human
  • RNA, Messenger
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Receptors, Dopamine D5
  • Interferon-beta
  • Interferon-gamma
  • Matrix Metalloproteinase 9
  • Dopamine